Product NDC: | 52125-134 |
Proprietary Name: | Divalproex SodiumDelayed-Release |
Non Proprietary Name: | Divalproex Sodium |
Active Ingredient(s): | 250 mg/1 & nbsp; Divalproex Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 52125-134 |
Labeler Name: | REMEDYREPACK INC. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090210 |
Marketing Category: | ANDA |
Start Marketing Date: | 20130225 |
Package NDC: | 52125-134-02 |
Package Description: | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-134-02) |
NDC Code | 52125-134-02 |
Proprietary Name | Divalproex SodiumDelayed-Release |
Package Description | 30 TABLET, FILM COATED in 1 BLISTER PACK (52125-134-02) |
Product NDC | 52125-134 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Divalproex Sodium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20130225 |
Marketing Category Name | ANDA |
Labeler Name | REMEDYREPACK INC. |
Substance Name | DIVALPROEX SODIUM |
Strength Number | 250 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC] |